Mihir Parmar
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 10%
- Pharmacology top 5%
- Physiology
- Biochemistry top 5%
- Co-authors
- Hatem M. AbuohashishMohammed M. AhmedSalim S. Al‐RejaieMohammad Shamsul OlaAbdulaziz M. AleisaAmal J. FataniAbdullah S. AlhomidaKhaled Alhosaini
- Topics
- Natural Antidiabetic Agents Studies (8 papers)Topic Modeling (7 papers)Drug-Induced Hepatotoxicity and Protection (7 papers)
- Partner nations
- Saudi ArabiaIndiaUnited States
In The Last Decade
Mihir Parmar
26 papers receiving 564 citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 154
- Endocrinology, Diabetes and Metabolism 117
- Pharmacology 101
- Physiology 88
- Biochemistry 86
Countries citing papers authored by Mihir Parmar
This map shows the geographic impact of Mihir Parmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihir Parmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihir Parmar more than expected).
Fields of papers citing papers by Mihir Parmar
This network shows the impact of papers produced by Mihir Parmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihir Parmar. The network helps show where Mihir Parmar may publish in the future.
Co-authorship network of co-authors of Mihir Parmar
This figure shows the co-authorship network connecting the top 25 collaborators of Mihir Parmar. A scholar is included among the top collaborators of Mihir Parmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihir Parmar. Mihir Parmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 22 | |
| 8 | 13 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 15 | |
| 12 | 3 | |
| 13 | 54 | |
| 14 | 45 | |
| 15 | 28 | |
| 16 | 58 | |
| 17 | 101 | |
| 18 | 62 | |
| 19 | 6 | |
| 20 | 14 |
About Mihir Parmar
Mihir Parmar is a scholar working on Drug Discovery, Pharmacology and Biochemistry, having authored 33 papers that have together received 587 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (8 papers), Topic Modeling (7 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). The work is most often cited by research in Biochemistry (86 citations), Drug Discovery (2 citations) and Pharmacology (101 citations). Mihir Parmar has collaborated with scholars based in Saudi Arabia, India and United States. Frequent co-authors include Hatem M. Abuohashish, Mohammed M. Ahmed, Salim S. Al‐Rejaie, Mohammad Shamsul Ola, Abdulaziz M. Aleisa, Amal J. Fatani, Abdullah S. Alhomida, Khaled Alhosaini, Chitta Baral and Abdullah Alassaf. Their work appears in journals such as The FASEB Journal, BMC Complementary and Alternative Medicine and Neurological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.